Paul F. Truex, Director at Anthera Pharmaceuticals Inc (ANTH), bought 5,000 shares at $1.34 ($7K) on 2017-09-07, disclosed to the SEC on 2017-09-07.
Open-market purchase of $7k ANTH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ANTH | SELL | 2012-02-17 | $118K | — | Filing → |
| ANTH | SELL | 2012-01-19 | $101K | — | Filing → |
| ANTH | SELL | 2011-12-16 | $95K | — | Filing → |